PetVivo Holdings, Inc.
PETVOTCCIK 1512922HealthcareFiscal year ends Mar 31
Reports and events: 288 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2211:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-043639 |
| 2026-09-2211:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-043641 |
| 2026-09-1520:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001099910-26-000264 |
| 2026-08-2013:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039397 |
| 2026-08-1420:58 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038477 |
| 2026-07-2922:10 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035053 |
| 2026-07-2718:28 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-034762 |
| 2026-06-2921:30 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001493152-26-031136 |
| 2026-06-2521:23 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030193 |
| 2026-06-1122:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-028172 |
| 2026-04-1720:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-017819 |
| 2026-03-2722:06 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-013009 |
| 2026-03-1621:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-010335 |
| 2026-03-1321:09 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001099910-26-000119 |
| 2026-03-0401:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008745 |
| 2026-02-1721:32 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001493152-26-007150 |
| 2026-01-2921:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004231 |
| 2026-01-2218:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-003220 |
| 2026-01-1621:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001099910-26-000031 |
| 2026-01-1418:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-002223 |
| 2025-11-1421:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023398 |
| 2025-11-0319:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020574 |
| 2025-10-3019:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-020203 |
| 2025-09-3010:03 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-016139 |
| 2025-08-1420:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011967 |
| 2025-07-1021:06 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001641172-25-018617 |
| 2025-06-2417:44 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016271 |
| 2025-06-2010:23 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-015708 |
| 2025-06-1619:36 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-015235 |
| 2025-06-1223:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001641172-25-014760 |
| 2025-05-0715:48 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-008992 |
| 2025-04-0819:35 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-003208 |
| 2025-03-3118:45 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-001616 |
| 2025-03-3110:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-001429 |
| 2025-03-2600:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-000658 |
| 2025-03-1017:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-009657 |
| 2025-02-2814:53 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008632 |
| 2025-02-1814:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-007121 |
| 2025-02-1814:33 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-007118 |
| 2025-02-1419:45 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001493152-25-006783 |
| 2025-02-1319:46 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-006395 |
| 2025-02-0416:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-004803 |
| 2025-01-0221:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-000086 |
| 2024-12-2622:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-052142 |
| 2024-11-1421:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045778 |
| 2024-10-1018:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-040705 |
| 2024-10-0115:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-038960 |
| 2024-09-2613:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-038223 |
| 2024-09-0621:00 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-035333 |
| 2024-08-1420:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032139 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.